<?xml version="1.0" encoding="UTF-8"?>
<ref id="B219-nutrients-13-00462">
 <label>219.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bays</surname>
    <given-names>H.E.</given-names>
   </name>
   <name>
    <surname>Ballantyne</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Kastelein</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Isaacsohn</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Braeckman</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Soni</surname>
    <given-names>P.N.</given-names>
   </name>
  </person-group>
  <article-title>Eicosapentaenoic acid ethyl ester (amr101) therapy in patients with very high triglyceride levels (from the multi-center, placebo-controlled, randomized, double-blind, 12-week study with an open-label extension [marine] trial)</article-title>
  <source>Am. J. Cardiol.</source>
  <year>2011</year>
  <volume>108</volume>
  <fpage>682</fpage>
  <lpage>690</lpage>
  <pub-id pub-id-type="doi">10.1016/j.amjcard.2011.04.015</pub-id>
  <pub-id pub-id-type="pmid">21683321</pub-id>
 </element-citation>
</ref>
